InsiderTrades

Form 4 for ZTS Zoetis

Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-25 · accession 0001555280-24-000339 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-11-26 2024-11-25 ZTS Polzer Robert J EVP M - OptEx $161.63 +3,477 4,306 +419% +$562.0K
D 2024-11-26 2024-11-25 ZTS Polzer Robert J EVP S - Sale+OE $177.46 -3,477 3,249 -52% -$617.0K
DM 2024-11-26 2024-11-25 ZTS Polzer Robert J EVP M - OptEx $0.00 -3,477 5,455 -39% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-25 M A 2,420 $162.07 6,726 D — —
2 Common Common Stock 2024-11-25 S D 3,477 $177.46 3,249 D — — (F1) The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.45 to $177.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Common Common Stock 2024-11-25 M A 1,057 $160.62 4,306 D — —
4 Derivative Stock Option 2024-11-25 M D 2,420 $0.00 4,840 D $162.07 · — to — 2,420 Common Stock (F8) Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. (F9) One-third of each option vests on the first, second and third anniversaries of the date of grant, February 8, 2023. (F6) Each option expires on the tenth anniversary of the date of grant.
5 Derivative Stock Option 2024-11-25 M D 1,057 $0.00 5,455 D — · — to — 1,057 Common Stock (F3) Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. (F7) 5,455 options granted February 8, 2022 at an exercise price of $201.30 per option. (F4) 1,057 options granted February 10, 2021 at an exercise price of $160.62 per option. (F5) Each option vests on the third anniversary of the date of grant. (F6) Each option expires on the tenth anniversary of the date of grant.